4.4 Article

Multifactorial mitigation strategy to reduce clinically relevant pancreatic fistula in high-risk pancreatojejunostomy following pancreaticoduodenectomy

期刊

PANCREATOLOGY
卷 21, 期 2, 页码 466-472

出版社

ELSEVIER
DOI: 10.1016/j.pan.2020.12.019

关键词

Pancreas; Pancreaticoduodenectomy; Pancreaticojejunostomy; Pancreatic fistula

向作者/读者索取更多资源

The study suggests that the use of a multifactorial mitigation strategy (MS) following pancreaticoduodenectomy (PD) can significantly reduce the occurrence of postoperative pancreatic fistula (POPF) in high-risk patients. Both Body Mass Index and MS were identified as independent predictors of POPF. Further investigation on personalized approaches for vulnerable patients is recommended.
Introduction: Postoperative pancreatic fistula (POPF) is the most dreadful complication of pancreaticoduodenectomy (PD) and previous literature focused on technical modifications of pancreatic remnant reconstruction. We developed a multifactorial mitigation strategy (MS) and the aim of the study is to assess its clinical impact in patients at high-risk of POPF. Methods: All patients candidate to PD between 2012 and 2018 were considered. Only patients with a high Fistula Risk Score (FRS 7-10) were included. Patients undergoing MS were compared to patients receiving Standard Strategy (SS). Clinical outcomes were compared between the two groups. Multivariate hierarchical logistic regression analyses were performed to detect independent predictors of POPF. Results: Out of 212 patients, 33 were finally included in MS Group and 29 in SS Group. POPF rate was significantly lower in MS Group (12.1% vs 44.8%, p = 0.005). Delayed gastric emptying, postoperative pancreatitis, complications and hospital stay were also significantly lower in MS Group. Hierarchical logistic regression analyses showed that Body Mass Index (OR = 1.196, p = 0.036) and MS (OR = 0.187, p = 0.032) were independently associated with POPF. Conclusion: A multifactorial MS can be helpful to reduce POPF rate in patients with high FRS following PD. Personalized approach for vulnerable patients should be investigated in the future. (C) 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据